Literature DB >> 24615684

An educational intervention to improve adherence to high-dosage patching regimen for amblyopia: a randomised controlled trial.

Archana Pradeep, Frank Antony Proudlock, Musarat Awan, Glen Bush, Jacqueline Collier, Irene Gottlob.   

Abstract

BACKGROUND: Previous reports suggest that adherence to patching is a major issue in amblyopia treatment. We tested with an unmasked randomised controlled clinical trial whether an intense educational/motivational intervention improves adherence when a high-dose regime is prescribed.
METHODS: 62 children with newly diagnosed amblyopia were randomly allocated into two treatment arms with and without educational/motivational intervention material. Both were prescribed patching 10 h/day, 6 days/week for a fixed period of 12 weeks. The intervention arm received an educational/motivational intervention before patching which included information booklets, video, a cartoon story book, sticker charts and a dedicated session with a researcher. The control arm received the usual clinical information. The primary outcome measure was adherence measured using electronic occlusion dose monitors where a success/failure binary outcome was used to account for participants who dropped out of the study defined as patching >4 h/day. Visual outcome, expressed as percentage visual deficit, was measured as secondary outcome.
RESULTS: The intervention increased adherence success rate from 45.2% in the control group to 80.6% in the intervention group (p=0.0027). However, visual outcome was not significantly better in the intervention group (p=0.190).
CONCLUSIONS: Our study shows that an intense educational/motivational intervention can improve adherence to patching to high prescribed doses although no significant improvement in visual outcome was observed. TRIALS REGISTRATION NUMBER: ISRCTN05346737 (International Standard Randomised Controlled Trial Number Register).

Entities:  

Mesh:

Year:  2014        PMID: 24615684     DOI: 10.1136/bjophthalmol-2013-304187

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  7 in total

Review 1.  The treatment of amblyopia: current practice and emerging trends.

Authors:  Eleni Papageorgiou; Ioannis Asproudis; Gail Maconachie; Evangelia E Tsironi; Irene Gottlob
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-01-31       Impact factor: 3.117

2.  A pilot randomized clinical trial of intermittent occlusion therapy liquid crystal glasses versus traditional patching for treatment of moderate unilateral amblyopia.

Authors:  Jingyun Wang; Daniel E Neely; Jay Galli; Joshua Schliesser; April Graves; Tina G Damarjian; Jessica Kovarik; James Bowsher; Heather A Smith; Dana Donaldson; Kathryn M Haider; Gavin J Roberts; Derek T Sprunger; David A Plager
Journal:  J AAPOS       Date:  2016-07-12       Impact factor: 1.220

3.  Improved monitoring of adherence with patching treatment using a microsensor and Eye Patch Assistant.

Authors:  Jingyun Wang; Hongxin Xu; Bryan De La Cruz; Sarah E Morale; Reed M Jost; David A Leske; Jonathan M Holmes; Eileen E Birch
Journal:  J AAPOS       Date:  2020-03-18       Impact factor: 1.220

Review 4.  The challenges of amblyopia treatment.

Authors:  Gail D E Maconachie; Irene Gottlob
Journal:  Biomed J       Date:  2016-02-28       Impact factor: 4.910

Review 5.  Development of a core outcome set for amblyopia, strabismus and ocular motility disorders: a review to identify outcome measures.

Authors:  Samia Al Jabri; Jamie Kirkham; Fiona J Rowe
Journal:  BMC Ophthalmol       Date:  2019-02-08       Impact factor: 2.209

Review 6.  Simplified updates on the pathophysiology and recent developments in the treatment of amblyopia: A review.

Authors:  Santhan K S Gopal; Jai Kelkar; Aditya Kelkar; Abhishek Pandit
Journal:  Indian J Ophthalmol       Date:  2019-09       Impact factor: 1.848

Review 7.  Childhood amblyopia: current management and new trends.

Authors:  Vijay Tailor; Manuela Bossi; John A Greenwood; Annegret Dahlmann-Noor
Journal:  Br Med Bull       Date:  2016-08-19       Impact factor: 4.291

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.